Secondary Logo

Journal Logo

February 2014 - Volume 40 - Issue 2
pp: 173-342



Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: Phase 3 study

Modi, Satish S.; Lehmann, Robert P.; Walters, Thomas R.; More

Journal of Cataract and Refractive Surgery. 40(2):203-211, February 2014.



Multifocal intraocular lenses: Relative indications and contraindications for implantation

Braga-Mele, Rosa; Chang, David; Dewey, Steven; More

Journal of Cataract and Refractive Surgery. 40(2):313-322, February 2014.




Show: